These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36982465)

  • 1. HDL Function and Size in Patients with On-Target LDL Plasma Levels and a First-Onset ACS.
    Cordero A; Muñoz-García N; Padró T; Vilahur G; Bertomeu-González V; Escribano D; Flores E; Zuazola P; Badimon L
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of triglycerides to high density lipoprotein ratio in patients with first attack of acute coronary syndrome.
    Basuliman AS; Malabarey MA; Abousamak FW; Alyousef BY; Alrabea SS; Alshabibi RA; Aseri ZAA
    Saudi Med J; 2023 Apr; 44(4):379-384. PubMed ID: 37062558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome.
    Kidawa M; Gluba-Brzózka A; Zielinska M; Franczyk B; Banach M; Rysz J
    Curr Vasc Pharmacol; 2019; 17(4):365-375. PubMed ID: 29852873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which one of LDL-C /HDL-C ratio and non-HDL-C can better predict the severity of coronary artery disease in STEMI patients.
    Gao P; Wen X; Ou Q; Zhang J
    BMC Cardiovasc Disord; 2022 Jul; 22(1):318. PubMed ID: 35843962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between neutrophil/lymphocyte ratio combined with low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with acute coronary syndrome].
    Yuan S; Pu T; Wang Z; Li L; Gao P; Zhang L; Ma Y; Qi Q; Fan X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Mar; 34(3):274-279. PubMed ID: 35574745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome.
    Koncsos P; Fülöp P; Juhász I; Bíró K; Márk L; Simonyi G; Paragh G
    Wien Klin Wochenschr; 2016 Dec; 128(23-24):858-863. PubMed ID: 27380508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease.
    Meikle PJ; Formosa MF; Mellett NA; Jayawardana KS; Giles C; Bertovic DA; Jennings GL; Childs W; Reddy M; Carey AL; Baradi A; Nanayakkara S; Wilson AM; Duffy SJ; Kingwell BA
    J Am Heart Assoc; 2019 Jun; 8(11):e011792. PubMed ID: 31131674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL functions and their interaction in patients with ST elevation myocardial infarction: a case control study.
    Thakkar H; Vincent V; Roy A; Singh S; Ramakrishnan L; Kalaivani M; Singh A
    Lipids Health Dis; 2020 Apr; 19(1):75. PubMed ID: 32293456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels.
    Annema W; Willemsen HM; de Boer JF; Dikkers A; van der Giet M; Nieuwland W; Muller Kobold AC; van Pelt LJ; Slart RH; van der Horst IC; Dullaart RP; Tio RA; Tietge UJ
    J Clin Lipidol; 2016; 10(6):1318-1328. PubMed ID: 27919348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial.
    Eppinga RN; Hartman MH; van Veldhuisen DJ; Lexis CP; Connelly MA; Lipsic E; van der Horst IC; van der Harst P; Dullaart RP
    PLoS One; 2016; 11(1):e0145719. PubMed ID: 26808474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of small dense low-density lipoprotein cholesterol and triglyceride-rich lipoproteins on plaque rupture with ST-segment elevation myocardial infarction.
    Arai T; Sekimoto T; Koba S; Mori H; Matsukawa N; Sakai R; Yokota Y; Sato S; Tanaka H; Masaki R; Oishi Y; Ogura K; Arai K; Nomura K; Sakai K; Tsujita H; Kondo S; Tsukamoto S; Suzuki H; Shinke T
    J Clin Lipidol; 2022; 16(5):725-732. PubMed ID: 36038471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goals of non-high density lipoprotein cholesterol need to be adjusted in Chinese acute coronary syndrome patients: Findings from the CCC-ACS project.
    Su X; Luo M; Tang X; Luo Y; Zheng X; Peng D;
    Clin Chim Acta; 2019 Sep; 496():48-54. PubMed ID: 31255567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Associations between various lipid components and premature myocardial infarction: a cross-sectional study].
    Shi J; Zhang HY; Wang DY; Gao Q; Sheng L; Song PW; Zhang Y; Li Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Mar; 51(3):278-287. PubMed ID: 36925138
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of atherogenic lipoprotein-cholesterol to HDL cholesterol ratio as a prognostic test for ST-segment elevation myocardial infarction.
    Li JY; Xu WJ; Zhou Z; Zhang RL; Sun T; Xu H; Wu J
    Int J Med Sci; 2021; 18(13):2897-2904. PubMed ID: 34220316
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of small dense low-density lipoprotein concentration for predicting the risk of acute coronary syndrome in Chinese population.
    Wu B; Yu Z; Tong T; Tong X; Yang Y; Tang Y; Ren H; Liao Y; Liao J
    J Clin Lab Anal; 2020 Mar; 34(3):e23085. PubMed ID: 31696980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of High-Density Lipoprotein (HDL) Quantity and Quality by Regular and Habitual Exercise in Middle-Aged Women with Improvements in Lipid and Apolipoprotein Profiles: Larger Particle Size and Higher Antioxidant Ability of HDL.
    Cho KH; Nam HS; Kang DJ; Zee S; Park MH
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
    Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
    BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.
    Dong M; Liao JK; Yan B; Li R; Zhang M; Yu CM
    Int J Cardiol; 2013 Sep; 167(6):2813-9. PubMed ID: 22921817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.